Copyright
©The Author(s) 2025.
World J Orthop. Sep 18, 2025; 16(9): 109147
Published online Sep 18, 2025. doi: 10.5312/wjo.v16.i9.109147
Published online Sep 18, 2025. doi: 10.5312/wjo.v16.i9.109147
Table 1 Main characteristics of orthobiologics used in hindfoot osteoarthritis treatment
| Treatment | Presence of growth factors | Presence of stem cells | Source |
| Corticosteroids | None | None | Exogenous |
| Viscosupplementation | None | None | Exogenous |
| Platelet-rich plasma | High | None | Peripheral blood |
| Bone marrow aspirate | High | Minimum | Bone marrow |
| Adipose derived stem cells | High | High | Adipose tissue |
Table 2 Stepwise treatment paradigm for hindfoot osteoarthritis
| HFOA stage | Recommended clinical approach | Remarks |
| Early stage | Weight reduction | Prioritize conservative measures |
| Physical therapy and activity modification | Injections may provide short- to midterm symptomatic relief | |
| Intra-articular hyaluronic acid injection (alone or with corticosteroids) | ||
| Intermediate stage | Limited repetition of corticosteroid injections during flare-ups | Careful patient selecion is key |
| Orthobiologic therapies (e.g., PRP, adipose derived stem cells) | Protocols and supporting evidence are still evolving | |
| Advanced stage | Surgical intervention (e.g., subtalar or triple arthrodesis) | Consider biomechanical implications and risk of adjacente joint overload |
- Citation: Gomes FF, de Castro Junior IM, Matheus Guimaraes JA, Rosa IM, de Sousa EB, Cordeiro A. Intra-articular treatments for hindfoot osteoarthritis. World J Orthop 2025; 16(9): 109147
- URL: https://www.wjgnet.com/2218-5836/full/v16/i9/109147.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i9.109147
